Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Relic

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Australasian Journal of Dermatology|August 30, 2018
Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?Adam G Harris, Samra L Saikal, Jim Scurry, et al.
Acta Dermato-Venereologica|September 10, 2008
Differential expression of pyloric atresia in junctional epidermolysis bullosa with ITGB4 mutations suggests that pyloric atresia is due to factors other than the mutations and not predictive of a poor outcome: three novel mutations and a review of the literatureNingning Dang, Sandra Klingberg, Adam I Rubin, et al.
The Australasian Journal of Dermatology|March 11, 2015
Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statementEmma Mooney, Marius Rademaker, Rebecca Dailey, et al.
The Australasian Journal of Dermatology|March 3, 2017
Consensus statement for the treatment of infantile haemangiomas with propranololSarah L Smithson, Marius Rademaker, Susan Adams, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Australasian Journal of Dermatology|August 30, 2018
Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?Adam G Harris, Samra L Saikal, Jim Scurry, et al.
Acta Dermato-Venereologica|September 10, 2008
Differential expression of pyloric atresia in junctional epidermolysis bullosa with ITGB4 mutations suggests that pyloric atresia is due to factors other than the mutations and not predictive of a poor outcome: three novel mutations and a review of the literatureNingning Dang, Sandra Klingberg, Adam I Rubin, et al.
The Australasian Journal of Dermatology|March 11, 2015
Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statementEmma Mooney, Marius Rademaker, Rebecca Dailey, et al.
The Australasian Journal of Dermatology|March 3, 2017
Consensus statement for the treatment of infantile haemangiomas with propranololSarah L Smithson, Marius Rademaker, Susan Adams, et al.
Pageof 2